发明名称 AMPHIPATHIC MOLECULES AS CHOLESTEROL AND OTHER LIPID UPTAKE INHIBITORS
摘要 Cholesterol biosynthesis can be inhibited by suitable inhibitors, such as the statins. However, hypercholesterolaemia, whether familial or diet-induced, and more generally hyperlipidaemia are not adequately addressed by cholesterol biosynthesis inhibitors alone, since the body's cholesterol is acquired by uptake from the diet as well as by endogenous synthesis. Lipid is also taken up from the gut. This problem is addressed by providing one or more molecules having amphipathic regions to inhibit the uptake of cholesterol, and other lipids, from the gut. Obesity may also be treated or prevented in this way, as may atherosclerosis. Examples of suitable molecules having amphipathic regions include natural or variant apoproteins and other proteins and peptides having an amphipathic .alpha.-helix composed of at least about 15 amino acids.
申请公布号 CA2249459(A1) 申请公布日期 1997.10.09
申请号 CA19972249459 申请日期 1997.03.27
申请人 BOFFELLI, DARIO;HAUSER, HELMUT 发明人 BOFFELLI, DARIO;HAUSER, HELMUT
分类号 A61K47/42;A61K31/00;A61K31/365;A61K31/366;A61K38/00;A61K45/08;A61P3/00;A61P3/06;A61P9/00;A61P9/10;C07K14/475;C07K14/775;(IPC1-7):A61K38/17;A61K38/10;A61K38/14 主分类号 A61K47/42
代理机构 代理人
主权项
地址